Article ID Journal Published Year Pages File Type
3848285 American Journal of Kidney Diseases 2013 7 Pages PDF
Abstract
Peginterferon alfa-2b and ribavirin combination therapy provided a higher SVR rate than peginterferon alfa-2b monotherapy for treatment-naive dialysis patients with chronic HCV infection through careful monitoring of hematologic parameters and ribavirin dose modification. Severe anemia was significantly higher in patients receiving combination therapy than patients treated with monotherapy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
Efficacy and Safety of Pegylated Interferon Alfa-2b and Ribavirin Combination Therapy Versus Pegylated Interferon Monotherapy in Hemodialysis Patients: A Comparison of 2 Sequentially Treated Cohorts
Authors
, , , , , , , , , , , , ,